Rare diseases
Expansion into new international biotech markets can be challenging. Unfamiliar regulations and licensing, coupled with language and cultural differences, can all be barriers to growth. If you’re considering venturing into Europe and beyond, our easy-to-follow guides, shaped by 30 years of expertise in the rare disease market, will assist you in navigating challenges and gaining a profound understanding of the complexities involved in launching orphan drugs into new markets. To learn more about how Sciensus can facilitate and support your Europan expansion, visit: Rare Diseases and Orphan Drugs
News, Rare diseases
Sciensus hosts a panel at the World Orphan Drug Congress 2024
Thought Leadership, Rare diseases
The impact of real-world data in gaining access to the European orphan drugs market.
News, Rare diseases
Sciensus partners with ITN and Genetic Alliance UK for Rare Disease Day
Thought Leadership, Rare diseases
Navigating early access in Europe: a strategic blueprint for biotech leaders
Blogs/Articles, Rare diseases
Accessing and supporting EU rare disease patients: a quick guide
Blogs/Articles, Rare diseases
Early access programs – benefits, challenges and the Sciensus solution
Case Studies, Rare diseases
Developing a comprehensive support program in Europe
Case Studies, Rare diseases
How Sciensus supported the launch of a breakthrough therapy in Europe
Thought Leadership, Rare diseases
Strategies for entering the European orphan drugs market